GlassScriptPhysician profile
William W Borron
NPI 1790786861
$13,881.55
in general payments reported to CMS, 2019-2025
41 companies · $2,773 in 2025
The $2,773 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,838 · 2020: $591 · 2021: $1,492 · 2022: $2,530 · 2023: $2,557 · 2024: $2,100 · 2025: $2,773.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,341 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,341.04 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $3,682.82 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $2,508.72 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $977.56 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Genzyme Corporation | $744.70 | 2019-2025 | |
| Grifols USA, LLC | $735.43 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $596.32 | 2021-2025 | Dupixent |
| Actelion Pharmaceuticals US, INC. | $498.98 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Mylan Specialty L.P. | $489.25 | 2019-2024 | Yupelri |
| Baxter Healthcare | $375.75 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $368.35 | 2019-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $259.77 | 2019-2023 | Tyvaso |
| Genentech USA, INC. | $227.00 | 2019-2022 | |
| Inspire Medical Systems, INC. | $221.24 | 2023-2025 | Inspire |
| Viatris Specialty LLC | $211.31 | 2025 | Yupelri |
| Verona Pharma, INC. | $202.86 | 2025 | Ohtuvayre |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $157.20 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $155.18 | 2024-2025 | Purified Cortrophin Gel |
| Electromed, INC. | $149.19 | 2022-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $137.56 | 2023-2025 | Zerbaxa |
| Novartis Pharmaceuticals Corporation | $111.03 | 2020-2023 | |
| Paratek Pharmaceuticals, INC. | $110.90 | 2023-2025 | Nuzyra |
| Philips North America LLC | $110.44 | 2019-2025 | Vest Therapy Und |
| Sunovion Pharmaceuticals INC. | $100.78 | 2019-2020 | |
| Amgen INC. | $83.91 | 2023-2025 | Tezspire |
| Janssen Pharmaceuticals, INC | $73.43 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $67.93 | 2019-2021 | |
| Circassia INC. | $65.14 | 2019 | |
| Abbvie INC. | $56.66 | 2023-2025 | Avycaz |
| Lilly USA, LLC | $55.75 | 2025 | Zepbound |
| Medtronic, INC. | $44.61 | 2024 | Illumisite |
| E.R. Squibb & Sons, L.L.C. | $41.66 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.23 | 2021-2022 | |
| Gilead Sciences, INC. | $29.99 | 2021 | |
| Alexion Pharmaceuticals, INC. | $29.73 | 2023 | Ultomiris |
| Itamar Medical INC | $27.51 | 2024 | Watchpatone |
| Beckman Coulter, INC. | $25.47 | 2024 | Dxh 900 Hematology System |
| Harmony Biosciences LLC | $25.39 | 2025 | |
| Zoll Respicardia, INC. | $24.01 | 2024 | Remede System |
| Pulmonx Corporation | $22.76 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.03 | 2020 | |
| Pfizer INC. | $18.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Borron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.